Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
International Journal of Molecular Sciences
|
September 27, 2025
Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore
Andrea Camerini, Alessandro Inno, Maria Laura Canale, et al.
Journal of Cardiovascular Pharmacology
|
September 26, 2025
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology Patients
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.
Plos One
|
May 26, 2016
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study
Stefania Gori, Alessandro Inno, Valentina Rossi, et al.
Oncotarget
|
January 23, 2016
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
Marzia Del Re, Marcello Tiseo, Paola Bordi, et al.
Cardio-Oncology (London, England)
|
June 19, 2026
Environmental endocrine disruptors in cardio-oncology: emerging modifiers of cardiovascular vulnerability in patients with cancer
Vincenzo Quagliariello, Massimiliano Berretta, Giuseppe D'Aiuto, et al.
Clinical Breast Cancer
|
June 18, 2019
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer
Stefania Gori, Fabio Puglisi, Stefano Moroso, et al.
Journal of Cardiovascular Pharmacology
|
January 27, 2026
Evidence of Cardiotoxic Immune Activation by Triple Immune Checkpoint Blockade: A Translational Alert for Clinical Surveillance in cancer patients
Vincenzo Quagliariello, Margherita Passariello, Martina Belardo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 29, 2018
PD-L1 Expression Heterogeneity in Non-Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections
Enrico Munari, Giuseppe Zamboni, Gianluigi Lunardi, et al.
Giornale Italiano Di Cardiologia (2006)
|
September 29, 2024
[Atherosclerosis, cancer and immune checkpoint inhibitors]
Maria Laura Canale, Alessandra Greco, Alessandro Inno, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2022
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study
Maria V Dieci, Giuseppe Azzarello, Vittorina Zagonel, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
International Journal of Molecular Sciences
|
September 27, 2025
Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore
Andrea Camerini, Alessandro Inno, Maria Laura Canale, et al.
Journal of Cardiovascular Pharmacology
|
September 26, 2025
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology Patients
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.
Plos One
|
May 26, 2016
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study
Stefania Gori, Alessandro Inno, Valentina Rossi, et al.
Oncotarget
|
January 23, 2016
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
Marzia Del Re, Marcello Tiseo, Paola Bordi, et al.
Cardio-Oncology (London, England)
|
June 19, 2026
Environmental endocrine disruptors in cardio-oncology: emerging modifiers of cardiovascular vulnerability in patients with cancer
Vincenzo Quagliariello, Massimiliano Berretta, Giuseppe D'Aiuto, et al.
Clinical Breast Cancer
|
June 18, 2019
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer
Stefania Gori, Fabio Puglisi, Stefano Moroso, et al.
Journal of Cardiovascular Pharmacology
|
January 27, 2026
Evidence of Cardiotoxic Immune Activation by Triple Immune Checkpoint Blockade: A Translational Alert for Clinical Surveillance in cancer patients
Vincenzo Quagliariello, Margherita Passariello, Martina Belardo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 29, 2018
PD-L1 Expression Heterogeneity in Non-Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections
Enrico Munari, Giuseppe Zamboni, Gianluigi Lunardi, et al.
Giornale Italiano Di Cardiologia (2006)
|
September 29, 2024
[Atherosclerosis, cancer and immune checkpoint inhibitors]
Maria Laura Canale, Alessandra Greco, Alessandro Inno, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2022
Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep 2020-May 2021) in the Veneto Oncology Network: The ROVID study
Maria V Dieci, Giuseppe Azzarello, Vittorina Zagonel, et al.
Page
of 11